LLA.L,0P0001T9GN,0
LLA.L,0P0001T9GN,0
Share · USU5500L1128 (XLON)
Overview
No Price
Closing Price XLON 22.05.2025: 5,00 GBX
n/a
1 day
-
1 week
-
1 month
-
3 months
-
6 months
-
Year to date
-
1 year
-
2 years
-
3 years
-
4 years
-
5 years
-
10 years
-
20 years
-
Max
-
Current Prices from LLA.L,0P0001T9GN,0
ExchangeTickerCurrencyLast TradePriceDaily Change
XLON: London
London
LLA.L
GBX
22.05.2025 11:03
5,00 GBX
-
Company Profile for LLA.L,0P0001T9GN,0 Share
LungLife AI, Inc., a diagnostic company, researches and develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology in the United States and the People's Republic of China. The company engages in developing LungLB, a blood-based test to stratify cancerous and benign lung nodules identified by CT scan. The company was formerly known as Cynvenio Biosystems, Inc. and changed its name to LungLife AI, Inc. in May 2019. LungLife AI, Inc. was incorporated in 2009 and is based in Thousand Oaks, California.

Company Data

Name LLA.L,0P0001T9GN,0
Company LungLife AI, Inc.
Website https://lunglifeai.com
Primary Exchange XLON London
ISIN USU5500L1128
Asset Class Share
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO Paul Pagano
Country United States of America
Currency GBX
Employees 0,0 T
Address 2545 West Hillcrest Drive, 91320 Thousand Oaks
IPO Date 2024-06-26

Ticker Symbols

Name Symbol
London LLA.L
More Shares
Investors who hold LLA.L,0P0001T9GN,0 also have the following shares in their portfolio:
FLUGH.ZUER. 13-23
FLUGH.ZUER. 13-23 Bond
WTS LKD ORDS MOTHERSON SUMI 22/11/23
WTS LKD ORDS MOTHERSON SUMI 22/11/23 Verbriefte Derivate
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025